(Q38447327)
English
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full d
scientific article published on 24 July 2013
Statements
Side effects of Bacillus Calmette-Guérin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance BCG (English)
Maurizio Brausi
Richard Sylvester
Aldo Bono
Cees van de Beek
George van Andel
Levent Turkeri
Sandrine Marreaud
Sandra Collette
Willem Oosterlinck